— Know what they know.
Not Investment Advice

SNOA NASDAQ

Sonoma Pharmaceuticals, Inc.
1W: -2.4% 1M: -3.9% 3M: -0.8% YTD: -65.9% 1Y: -67.9% 3Y: -92.2% 5Y: -98.8%
$1.24
-0.01 (-0.80%)
 
Weekly Expected Move ±4.7%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · $5.9M mcap · 5M float · 2.71% daily turnover · Short 19% of daily vol

📊 Key Metrics

TTM
$20M
Revenue
+36.7% YoY
$-3M
Net Income
+8.2% YoY
$-4M
Free Cash Flow
-1299.3% YoY
39.2%
Gross Margin
-6.3%
Op. Margin
-10.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-84.6%
ROA-23.0%
ROIC-126.4%

Valuation

P/E-1.0
P/B0.7
EV/EBITDA-0.9

Leverage

Debt/Equity0.27
Current Ratio2.50
Interest Cov.0.0x

Quality Scores

Piotroski F2/9
Altman Z-18.51
Beneish M-1.83

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms